NZ565695A - Immunogenic constructs containing polypetide sequences of ahpC, gsd, p12 and mpa - Google Patents
Immunogenic constructs containing polypetide sequences of ahpC, gsd, p12 and mpaInfo
- Publication number
- NZ565695A NZ565695A NZ565695A NZ56569506A NZ565695A NZ 565695 A NZ565695 A NZ 565695A NZ 565695 A NZ565695 A NZ 565695A NZ 56569506 A NZ56569506 A NZ 56569506A NZ 565695 A NZ565695 A NZ 565695A
- Authority
- NZ
- New Zealand
- Prior art keywords
- seq
- polypeptide
- amino acids
- sequence
- polynucleotide
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/023—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a poxvirus
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US70659405P | 2005-08-09 | 2005-08-09 | |
| PCT/GB2006/002893 WO2007017635A1 (en) | 2005-08-09 | 2006-08-03 | Immunogenic constructs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ565695A true NZ565695A (en) | 2011-01-28 |
Family
ID=36992793
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ565695A NZ565695A (en) | 2005-08-09 | 2006-08-03 | Immunogenic constructs containing polypetide sequences of ahpC, gsd, p12 and mpa |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US7892566B2 (https=) |
| EP (1) | EP1913020B1 (https=) |
| JP (1) | JP5244593B2 (https=) |
| AT (1) | ATE466876T1 (https=) |
| AU (1) | AU2006277828B2 (https=) |
| CA (1) | CA2617506C (https=) |
| DE (1) | DE602006014164D1 (https=) |
| DK (1) | DK1913020T3 (https=) |
| ES (1) | ES2345274T3 (https=) |
| NZ (1) | NZ565695A (https=) |
| WO (1) | WO2007017635A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9806093D0 (en) | 1998-03-20 | 1998-05-20 | Taylor John Hermon | Diagnostics and vaccines for mycobacterial infections of animals and humans |
| ATE466876T1 (de) * | 2005-08-09 | 2010-05-15 | Hav Vaccines Ltd | Immunogene konstrukte |
| GB201700487D0 (en) * | 2017-01-11 | 2017-02-22 | Hermon-Taylor John | Diagnostic |
| CN109125740B (zh) * | 2017-06-28 | 2022-04-05 | 成都威斯克生物医药有限公司 | 一种新型的肿瘤疫苗及其用途 |
| GB201811382D0 (en) * | 2018-07-11 | 2018-08-29 | Taylor John Hermon | Vaccine |
| WO2026041756A1 (en) * | 2024-08-21 | 2026-02-26 | Hav Vaccines Limited | Treatment of crohn's disease by mycobacterium avium subsp. paratuberculosis agent |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5225324A (en) * | 1987-04-24 | 1993-07-06 | Bioscience International, Inc. | Diagnostics for mycobacteria in public health, medical, and veterinary practice |
| GB8709803D0 (en) | 1987-04-24 | 1987-05-28 | Mcfadden J J | Treatment of crohn's disease &c |
| FR2682967B1 (fr) | 1991-10-25 | 1994-01-14 | Pasteur Institut | Nouveau promoteur de m. paratuberculosis. son utilisation pour le clonage et l'expression de sequences nucleotidiques. |
| AU708456B2 (en) * | 1994-12-20 | 1999-08-05 | New Zealand Pastoral Agriculture Research Institute Limited | Methods and compositions for detecting and treating mycobacterial infections using an ahpCF operon |
| GB9526178D0 (en) | 1995-12-21 | 1996-02-21 | Taylor John Hermon | Novel polynuceotides and polypeptides in pathogenic mycobacteria and their use as diagnostics,vaccines and targets for chemotherapy |
| GB9806093D0 (en) | 1998-03-20 | 1998-05-20 | Taylor John Hermon | Diagnostics and vaccines for mycobacterial infections of animals and humans |
| EP2196473A1 (en) * | 2001-07-04 | 2010-06-16 | Health Protection Agency | Mycobacterial antigens expressed during latency |
| WO2003009868A1 (en) * | 2001-07-26 | 2003-02-06 | Otago Innovation Limited | Antigenic compositions |
| JP2005514041A (ja) * | 2002-01-11 | 2005-05-19 | イーデー−レリースタツト・インステイテユート・フオール・デイールホウデライ・エイ・デイールゲゾントハイト・ベー・ベー | ミコバクテリウム・パラツベルクローシス感染の診断薬及びワクチン |
| ATE466876T1 (de) * | 2005-08-09 | 2010-05-15 | Hav Vaccines Ltd | Immunogene konstrukte |
-
2006
- 2006-08-03 AT AT06765201T patent/ATE466876T1/de not_active IP Right Cessation
- 2006-08-03 AU AU2006277828A patent/AU2006277828B2/en active Active
- 2006-08-03 ES ES06765201T patent/ES2345274T3/es active Active
- 2006-08-03 CA CA2617506A patent/CA2617506C/en active Active
- 2006-08-03 NZ NZ565695A patent/NZ565695A/en unknown
- 2006-08-03 US US11/997,627 patent/US7892566B2/en active Active
- 2006-08-03 DE DE602006014164T patent/DE602006014164D1/de active Active
- 2006-08-03 DK DK06765201.6T patent/DK1913020T3/da active
- 2006-08-03 JP JP2008525615A patent/JP5244593B2/ja active Active
- 2006-08-03 WO PCT/GB2006/002893 patent/WO2007017635A1/en not_active Ceased
- 2006-08-03 EP EP06765201A patent/EP1913020B1/en active Active
-
2011
- 2011-01-14 US US13/007,062 patent/US8147850B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007017635A1 (en) | 2007-02-15 |
| AU2006277828A1 (en) | 2007-02-15 |
| EP1913020B1 (en) | 2010-05-05 |
| EP1913020A1 (en) | 2008-04-23 |
| ES2345274T3 (es) | 2010-09-20 |
| US8147850B2 (en) | 2012-04-03 |
| US7892566B2 (en) | 2011-02-22 |
| JP5244593B2 (ja) | 2013-07-24 |
| DK1913020T3 (da) | 2010-08-09 |
| DE602006014164D1 (de) | 2010-06-17 |
| US20110129502A1 (en) | 2011-06-02 |
| AU2006277828B2 (en) | 2012-02-02 |
| CA2617506C (en) | 2015-02-03 |
| CA2617506A1 (en) | 2007-02-15 |
| JP2009504149A (ja) | 2009-02-05 |
| ATE466876T1 (de) | 2010-05-15 |
| US20090203593A1 (en) | 2009-08-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12324834B2 (en) | Nucleic acid vaccine against the SARS-CoV-2 coronavirus | |
| CN115246874B (zh) | 一种重组新型冠状病毒s-rbd三聚体蛋白、其制备方法和应用 | |
| US8147850B2 (en) | Immunogenic constructs | |
| US20250152691A1 (en) | Immunogenic composition for paratuberculosis | |
| KR101955365B1 (ko) | 신규한 클로스트리듐 디피실(Clostridium Difficile) DNA 백신 | |
| US20120003241A1 (en) | Vaccine against botulism | |
| WO1997013858A2 (en) | Baboon mage-3 homologs, dna encoding the homologs, and a process for their use | |
| AU2011201813A1 (en) | Poxvirus vector encoding prostate specific antigens for treatment of prostate cancer | |
| US20130273093A1 (en) | Method for Immunising a Subject against Mycobacterium Tuberculosis or Mycobacterium Bovis | |
| Paterson | Rational approaches to immune regulation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ASS | Change of ownership |
Owner name: HAV VACCINES LIMITED, GB Free format text: OLD OWNER(S): ST. GEORGE'S ENTERPRISES LIMITED |
|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 03 AUG 2016 BY CPA GLOBAL Effective date: 20130711 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 03 AUG 2017 BY CPA GLOBAL Effective date: 20160617 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 03 AUG 2018 BY CPA GLOBAL Effective date: 20170622 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 03 AUG 2019 BY CPA GLOBAL Effective date: 20180622 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 03 AUG 2020 BY CPA GLOBAL Effective date: 20190620 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 03 AUG 2021 BY CPA GLOBAL Effective date: 20200618 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 03 AUG 2022 BY CPA GLOBAL Effective date: 20210617 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 03 AUG 2023 BY CPA GLOBAL Effective date: 20220616 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 03 AUG 2024 BY CPA GLOBAL Effective date: 20230622 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 03 AUG 2025 BY ABHISHEK KUMAR - CPA-PTO PAYMENTS Effective date: 20240620 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 03 AUG 2026 BY ABHISHEK KUMAR - CPA-PTO PAYMENTS Effective date: 20250619 |